Neuronano

Neuronano is an innovative Swedish medical technology (MedTech) company focused on developing a new generation of implantable electrodes for Deep Brain Stimulation (DBS). Its primary aim is to improve the quality of life for people with neurological illnesses such as Parkinson's disease, various types of pain and epilepsy. The company's core technology consists of thinner, more flexible and more biocompatible electrodes than those used in conventional DBS treatments, which is expected to result in better patient safety, fewer side effects and improved quality of life. Neuronano AB was founded in 2006 by Prof. Jens Schouenborg and investor Per-Anders Johansson, with the vision to create a patent portfolio of bio-friendly, implantable electrode technology as well as commercial products that can improve life for people, primarily with Parkinson's disease. The company is headquartered in Karlshamn, Sweden, and operates in the Swedish and international medical technology sector. Beyond DBS electrodes, Neuronano's project portfolio includes a Pro Active Tissue Stabilizer that uses an algorithm to predict future body movement and compensate for phase lag, and 3D Project Recording aimed at overcoming poor stability of neuronal recordings for long-term studies of individual neurons. The company's innovations are protected by a comprehensive patent portfolio covering surgical implantation methods, biocompatible ultra-flexible electrodes, gel-electrode constructions, local drug delivery, tissue stability and brain stimulation optimization. Neuronano's mission is to invent, patent, develop and commercialise a new generation of innovative electrodes for implantation in the brain and spinal cord, with a vision to develop groundbreaking "Neuro Modulation" technologies. The company maintains a stringent ethical compass and a focus on thoughtfulness and care for the people it aims to help.

Neuronano AB was founded in 2006 by Prof. Jens Schouenborg and investor Per-Anders Johansson with the vision to create a patent portfolio of bio-friendly, implantable electrode technology as well as commercial products that can improve life for people, primarily with Parkinson's disease. In the same year, the Neuronano Research Center (NRC) was started, led by Dr Jens Schouenborg. NRC is an interdisciplinary Research and Innovation center focusing on developing a new generation of neural interfaces for communication with the nervous system in basic research and clinical applications. NRC bridges two major science fields—neuroscience and nanoscience—and was established based on grants from the Knut and Alice Wallenberg foundation and a 10-year Linneaus grant from the Swedish Research Council (SRC). In 2017, Dr Jens Schouenborg and collaborators received a six-year grant to develop a new type of optrode. With researchers from the Faculties of Medicine, Engineering (LTH), Science, and Humanity, the Neuronano Research Center combines neuroscience (including neuroinformatics), nano and microtechnology, organic chemistry, and neuroethics. The vision of NRC is: "To develop Brain Machine Interfaces for groundbreaking neurophysiological research in the conscious individual and clinical applications that will improve 'quality of life' for disabled and individuals with neurodegenerative diseases." Neuronano has developed and patented a new generation of implantable electrodes for Deep Brain Stimulation (DBS) treatment. The solution comprises thinner, more flexible electrodes that are more biocompatible than those used in today's DBS treatments, which will most likely result in better patient safety, fewer side effects and improved quality of life. The company's innovations are protected by a comprehensive patent portfolio which is expanded as the company's research continues to make advances. The patent portfolio includes everything from solutions related to surgical implantation methods and apparatuses for implantation of electrodes and cells, biocompatible constructions comprising several types of implantable ultra flexible electrodes for recordings and stimulations, biocompatible gel-electrode constructions, biocompatible constructions for local drug delivery, constructions and procedures improving stability in tissue and procedures to optimize brain stimulation. Neuronano's mission is to invent, patent, develop and commercialise a new generation of innovative electrodes for implantation in the brain and spinal cord. Its vision is to develop groundbreaking "Neuro Modulation" technologies. The company is headquartered in Karlshamn, Sweden, and its future is considered very promising both for the company and for patients who currently suffer from or are limited by disease, and who may be helped by the technology tomorrow.

• 2017

  Dr Jens Schouenborg and collaborators received a six-year grant to develop a new type of optrode.

• 2006

  Neuronano AB founded by Prof. Jens Schouenborg and investor Per-Anders Johansson.

• 2006

  Neuronano Research Center (NRC) started, led by Dr Jens Schouenborg, based on grants from the Knut and Alice Wallenberg foundation and a 10-year Linneaus grant from the Swedish Research Council.

• 2006

  First patent application filed: PCT/SE2006/001124 Electrode Bundle.

Innovative Swedish MedTech company developing safer, more effective DBS electrodes for neurological diseases.

• Implantable electrodes for Deep Brain Stimulation (DBS)

  Thinner, more flexible and more biocompatible electrodes than those used in today's DBS treatments, expected to result in better patient safety, fewer side effects and improved quality of life.

• Pro Active Tissue Stabilizer

  Uses an algorithm to predict future body movement and move the Patient Positioning Platform to compensate the phase lag between compensatory movement and real movement.

• 3D Project Recording

  A solution to overcome the problem of poor stability of neuronal recordings, which impedes long-term studies of individual neurons in the brain.

1. 1Neuronano® | Welcome to Neuronano® – an innovative Swedish Med Tech company.neuronano.se
2. 2History | Neuronano®neuronano.se
3. 3Patents | Neuronano®neuronano.se
4. 4About us | Neuronano®neuronano.se
5. 5Neuronano (Sweden) - Wikidatawikidata.org